Open AccessNewly Approved Oral Chelation Therapy May Improve Adherence in Transfusion-Dependent Iron Overload
Author(s) -
Alice Goodman
Publication year - 2006
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000316076.88322.0f
Subject(s) - deferasirox , deferoxamine , medicine , chelation therapy , tolerability , thalassemia , deferiprone , myelodysplastic syndromes , blood transfusion , gastroenterology , surgery , adverse effect , bone marrow
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom